Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-4hcbs Total loading time: 0.24 Render date: 2021-12-07T10:28:06.412Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Benzodiazepine & nonbenzodiazepine prescriptions for Taiwanese elderly with type 2 diabetes contributes to cognitive dysfunction

Published online by Cambridge University Press:  15 May 2014

Yung-Rung Lai
Affiliation:
Department of Pharmacy, Chung Shan Medical University Hospital, Taichung, Taiwan
Yi-Sun Yang
Affiliation:
Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
Min-Ling Tsai
Affiliation:
Department of Pharmacy, Chung Shan Medical University Hospital, Taichung, Taiwan
Chien-Ning Huang
Affiliation:
Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
Jeng-Yuan Chiou*
Affiliation:
School of Health Policy and Management, Chung Shan Medical University, Taichung, Taiwan
*
Correspondence should be addressed to: Jeng-Yuan Chiou, PhD, School of Health Policy and Management, Chung Shan Medical University, No.110, Sec.1, Jianguo N.Rd., Taichung City 40201, Taiwan. Phone: +886-4-24739595; Ext.: 38140; Fax: +886-4-23248155. Email: tom@csmu.edu.tw.

Abstract

Background:

This study examined the relationship of cognitive function and benzodiazepine/nonbenzodiazepine hypnotics (BZD/nonBZD) and other risk factors in a national sample of Taiwan's elderly diabetic patients.

Methods:

Data were drawn from the “2005 Taiwan National Health Interview Survey (NHIS)”, a population-based study of a national sample of adults aged 65 years and older. A total of 653 participants were included in this study. The Mini-Mental State Examination (MMSE) was used to evaluate patient's cognitive function for which the cut-off score is education-adjusted.

Results:

There were 130 participants left in the diabetic group and 523 participants in the control group. The average age was 74.2 and 73.3 respectively. The rate of cognitive dysfunction in DM and non DM participants was 11.5% (15/130) and 8.4% (44/523). Compared with those without diabetes in multivariate logistic regression, the odds ratio of cognitive impairment was 1.87-fold higher for diabetic patients (95% CI 1.04–3.61) after adjusting for sociodemographic characteristics, comorbidities, and BZD/nonBZD. Other factors were not significant. We performed an additional logistic analysis for which the odds ratio of cognitive impairment in diabetic patients with BZD/nonBZD was significantly increased to 2.41 (95% CI 1.08–5.40) than for patients without diabetes and BZD/nonBZD.

Conclusion:

In our research, cognitive dysfunction was associated with diabetes. BZD/nonBZD may have conferred additional risk of cognitive impairment in our elderly diabetic patients. We should consider examining the mental function of DM patients regularly and try our best to avoid potentially inappropriate medications (PIMs).

Type
Research Article
Copyright
Copyright © International Psychogeriatric Association 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Geriatrics Society Beers Criteria Update Expert P. (2012). American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60, 616631. doi: 10.1111/j.1532-5415.2012.03923.x.CrossRefGoogle ScholarPubMed
Awad, N., Gagnon, M. and Messier, C. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26, 10441080. doi: 10.1080/13803390490514875.CrossRefGoogle ScholarPubMed
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C. and Scheltens, P. (2006). Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurology, 5, 6474. doi: 10.1016/S1474-4422(05)70284-2.CrossRefGoogle ScholarPubMed
Buscemi, N. et al. (2007). The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. Journal of General Internal Medicine, 22, 13351350. doi: 10.1007/s11606-007-0251-z.CrossRefGoogle ScholarPubMed
Crosby-Nwaobi, R., Sivaprasad, S. and Forbes, A. (2012). A systematic review of the association of diabetic retinopathy and cognitive impairment in people with Type 2 diabetes. Diabetes Research and Clinical Practice, 96, 101110. doi: 10.1016/j.diabres.2011.11.010.CrossRefGoogle ScholarPubMed
Cukierman, T., Gerstein, H. C. and Williamson, J. D. (2005). Cognitive decline and dementia in diabetes–systematic overview of prospective observational studies. Diabetologia, 48, 24602469. doi: 10.1007/s00125-005-0023-4.CrossRefGoogle ScholarPubMed
Cumming, R. G. and Le Couteur, D. G. (2003). Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs, 17, 825837.CrossRefGoogle Scholar
Euser, S. M., Schram, M. T., Hofman, A., Westendorp, R. G. and Breteler, M. M. (2008). Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology, 19, 440447. doi: 10.1097/EDE.0b013e31816a1d31.CrossRefGoogle Scholar
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.CrossRefGoogle ScholarPubMed
Glass, J., Lanctot, K. L., Herrmann, N., Sproule, B. A. and Busto, U. E. (2005). Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ, 331, 1169. doi: 10.1136/bmj.38623.768588.47.CrossRefGoogle ScholarPubMed
Grad, R. M. (1995). Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk. The Journal of Family Practice, 41, 473481.Google ScholarPubMed
Gray, S. L. et al. (2006). Benzodiazepine use and physical disability in community-dwelling older adults. Journal of the American Geriatrics Society, 54, 224230. doi: 10.1111/j.1532-5415.2005.00571.x.CrossRefGoogle ScholarPubMed
Guo, L. W., Liu, H. C. and Wong, P. F. (1988). Chinese version and norms of Mini-Mental State Examination. Journal of Chinese Rehabilitation Medicine, 16, 5259.Google Scholar
Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C. and King, D. (2000). Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ, 162, 225233.Google ScholarPubMed
Katz, S. and Akpom, C. A. (1976). A measure of primary sociobiological functions. International Journal of Health Services : Planning, Administration, Evaluation, 6, 493508.CrossRefGoogle ScholarPubMed
Knopman, D. S., Mosley, T. H., Catellier, D. J., Coker, L. H. and Atherosclerosis Risk in Communities Study Brain, M. R. I. S. (2009). Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimer's & Dementia, 5, 207214. doi: 10.1016/j.jalz.2009.01.027.CrossRefGoogle ScholarPubMed
Lai, H. Y., Hwang, S. J., Chen, Y. C., Chen, T. J., Lin, M. H. and Chen, L. K. (2009). Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clinical Therapeutics, 31, 18591870. doi: 10.1016/j.clinthera.2009.08.023.CrossRefGoogle ScholarPubMed
Lawton, M. P. and Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, 9, 179186.CrossRefGoogle ScholarPubMed
Liu, C. K. (2006). The epidemiology of dementia in Taiwan. Acta Neurologica Taiwanica, 15, 5152.Google ScholarPubMed
Liu, H. C. et al. (1995). Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals. Journal of the American Geriatrics Society, 43, 144149.CrossRefGoogle ScholarPubMed
Luchsinger, J. A., Reitz, C., Patel, B., Tang, M. X., Manly, J. J. and Mayeux, R. (2007). Relation of diabetes to mild cognitive impairment. Archives of Neurology, 64, 570575. doi: 10.1001/archneur.64.4.570.CrossRefGoogle ScholarPubMed
Nowell, P. D., Mazumdar, S., Buysse, D. J., Dew, M. A., Reynolds, C. F. 3rd and Kupfer, D. J. (1997). Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA, 278, 21702177.CrossRefGoogle ScholarPubMed
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303308.CrossRefGoogle ScholarPubMed
Ryan, C. M. and Geckle, M. O. (2000). Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care, 23, 14861493.CrossRefGoogle ScholarPubMed
Stewart, R. and Liolitsa, D. (1999). Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Medicine, 16, 93112.CrossRefGoogle ScholarPubMed
Strachan, M. W., Deary, I. J., Ewing, F. M. and Frier, B. M. (1997). Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care, 20, 438445.CrossRefGoogle ScholarPubMed
Strachan, M. W., Frier, B. M. and Deary, I. J. (2003). Type 2 diabetes and cognitive impairment. Diabetic Medicine, 20, 12.CrossRefGoogle ScholarPubMed
Strachan, M. W., Price, J. F. and Frier, B. M. (2008). Diabetes, cognitive impairment, and dementia. BMJ, 336, 6. doi: 10.1136/bmj.39386.664016.BE.CrossRefGoogle ScholarPubMed
Sussman, M. B. and Association, A. S. (1966). Sociology and Rehabilitation. Chicago, IL: American Sociological Association.Google Scholar
Tamblyn, R. M. et al. (1994). Questionable prescribing for elderly patients in Quebec. CMAJ, 150, 18011809.Google ScholarPubMed
Verdelho, A. et al. (2007). Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 13251330. doi: 10.1136/jnnp.2006.110361.CrossRefGoogle ScholarPubMed
Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 10471053.CrossRefGoogle ScholarPubMed
Yen, C. H. et al. (2010). Determinants of cognitive impairment over time among the elderly in Taiwan: results of the national longitudinal study. Archives of Gerontology and Geriatrics, 50 (Suppl. 1), S53–S57. doi: 10.1016/S0167-4943(10)70014-5.CrossRefGoogle ScholarPubMed
3
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Benzodiazepine & nonbenzodiazepine prescriptions for Taiwanese elderly with type 2 diabetes contributes to cognitive dysfunction
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Benzodiazepine & nonbenzodiazepine prescriptions for Taiwanese elderly with type 2 diabetes contributes to cognitive dysfunction
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Benzodiazepine & nonbenzodiazepine prescriptions for Taiwanese elderly with type 2 diabetes contributes to cognitive dysfunction
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *